Cetera Advisor Networks LLC Axogen, Inc. Transaction History

Cetera Advisor Networks LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 12, 2022	SELL	$7.26 - $10.7 $92,093 - $135,729	-12,685 Closed	0 $0
Q3 2021 Nov 16, 2021	BUY	$15.23 - $21.72 $193,192 - $275,518	12,685 New	12,685 $200,000
Q1 2021 May 17, 2021	SELL	$17.18 - $22.6 $231,930 - $305,100	-13,500 Closed	0 $0
Q1 2020 May 08, 2020	SELL	$8.38 - $17.34 $2,899 - $5,999	-346 Reduced 2.5%	13,500 $140,000
Q1 2019 May 06, 2019	SELL	$14.62 - $22.13 $87,603 - $132,602	-5,992 Reduced 30.2%	13,846 $291,000
Q4 2018 Feb 15, 2019	BUY	$17.09 - $38.25 $116,861 - $261,553	6,838 Added 52.6%	19,838 $405,000
Q3 2018 Nov 14, 2018	SELL	$34.05 - $55.9 $919,349 - $1.51 Million	-27,000 Reduced 67.5%	13,000 $479,000
Q2 2018 Aug 14, 2018	BUY	$36.15 - $52.5 $1.45 Million - $2.1 Million	40,000 New	40,000 $2.01 Million

179

36.2M

82.6K

1.1K

Ticker AXGN
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 42,283,700
Market Cap $759M
Description
AxoGen, Inc., together with its subsidiaries, develops and markets surgical solutions for physical damage or transection to peripheral nerves. The company's products include Avance Nerve Graft, a biologically active off-the-shelf processed human nerve allograft for bridging severed nerves without the comorbidities associated with a second surgic...

Get notified when there are updates to the investment portfolio of Cetera Advisor Networks LLC, based on Form 13F filings with the SEC.

Stay updated on Cetera Advisor Networks LLC with notifications on news.